Moreover, changes in the regulation of Arf1, such as, for example, those caused by mutations in ARFGAP2 encoding the Arf1 activating protein, manifest in chorea or microcephaly [79], the symptoms present in ChAc patients and Cohen syndrome patients. Here, ARFGAP2 is linked to choreatic disease.